Search

Learn about insights that could lead to a new class of drugs against cancers caused by RAS gene mutations.

… Wednesday, October 30, 2024 Each year, more than 3 million people are diagnosed with cancers driven by mutations in three RAS-family genes: KRAS, NRAS , and HRAS . RAS-family mutations are associated with numerous types of cancer. KRAS mutations are found in pancreatic cancer ,  colorectal cancer , 

Clues emerge about why promising new breast cancer drugs sometimes don’t work — and what might be done about it.

… Monday, December 10, 2018 Summary A new class of drugs called CDK4/6 inhibitors has been effective in women with breast cancer . However, some people don’t respond to the drugs, or they develop resistance over time. A study by MSK researchers has identified two genes linked to this resistance. The most

MSK performs the highest number of robot-assisted surgeries for colorectal cancer in the United States, enabling more patients to have a shorter hospital stay and a faster recovery.

… Thursday, March 14, 2024 When Robert Mendys was diagnosed with stage 3  rectal cancer  almost 10 years ago, he faced a profound dilemma. He wanted to make sure the cancer didn’t take him away from his wife and three young sons. But at only 46, he was very concerned about the long-term effects of surgical

MSK realiza la mayor cantidad de cirugías asistidas por robot para el cáncer colorrectal en los Estados Unidos, lo que permite que más pacientes tengan una estadía hospitalaria más corta y una recuperación más rápida.

… Thursday, March 14, 2024 Cuando Robert Mendys fue diagnosticado con cáncer de recto en estadio 3 hace casi 10 años, se enfrentó a un profundo dilema. Quería asegurarse de que el cáncer no lo alejara de su esposa y sus tres niños. Pero con solo 46 años, estaba muy preocupado por los efectos a largo plazo

Westchester Medical Center today announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with Memorial Sloan Kettering Cancer Center, whose staff will provide outpatient cancer care and infusion services.

… Wednesday, February 13, 2013 Westchester Medical Center (WMC) today announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with Memorial Sloan Kettering Cancer Center (MSKCC), whose staff will provide outpatient cancer care and infusion services.

The treatment that children receive for retinoblastoma can lead to health problems later in life. A new study documents their frequency and extent.

… Monday, February 1, 2016 Summary Retinoblastoma  is a rare childhood cancer that affects the eyes. It is highly treatable but can result in long-term medical consequences. A study conducted by MSK researchers documents the type and frequency of these consequences among survivors. The results will inform

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, November 2, 2023 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Mijin Kim Named A 2023 STAT Wunderkind Mijin Kim, PhD Mijin Kim, PhD, postdoctoral fellow, has been  honored   among the 2023 STAT Wunderkinds. STAT Wunderkinds acknowledges

Membership is a widely accepted mark of excellence in science and considered one of the highest honors a scientist can receive.

… Tuesday, April 28, 2020 Two Sloan Kettering Institute (SKI) researchers have been elected to the National Academy of Sciences (NAS). Scott Keeney, PhD , a molecular biologist, and Christopher Lima, PhD , a structural biologist, join more than a dozen Memorial Sloan Kettering investigators who are already

Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories.

… Friday, April 6, 2018 Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories. On Monday, April 16 at 6:30 p.m. , the Kaye Playhouse

Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and the Center for International Blood and Marrow Transplant Research (CIBMTR) on February 18.

… Monday, February 20, 2023 Miguel-Angel Perales, MD , of Memorial Sloan Kettering Cancer Center (MSK), has been named President of The American Society for Transplantation and Cellular Therapy (ASTCT) for 2023-2024. Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular